Paul Marshall and Ian Wace’s Top 5 Stock Picks

4. Bio-Rad Laboratories, Inc. (NYSE:BIO)

Marshall and Wace’s Stake Value: $280,330,000
Percentage of Paul Marshall and Ian Wace’s 13F Portfolio: 1.26%
Number of Hedge Fund Holders: 41

Bio-Rad Laboratories, Inc. (NYSE:BIO) is a life science research and clinical diagnostics company that develops, produces, and markets products. The company was founded in 1952 and is ranked fourth on the list of Paul Marshall and Ian Wace’s stock picks.

On July 29, Bio-Rad Laboratories, Inc. (NYSE:BIO) announced earnings for the second quarter of 2021. It posted earnings per share of $3.54, beating the estimates by $0.84. Revenue over the period was $715.9 million, up 33.3% YoY, surpassing the estimates by $73.29 million. 

The hedge fund chaired by Paul Marshall and Ian Wace holds 435,099 shares of Bio-Rad Laboratories, Inc. (NYSE:BIO), worth $280.33 million. Marshall Wace LLP has trimmed its stake in the firm by 24% in the second quarter of 2021. As of the second quarter of 2021, 41 hedge funds have positions in Bio-Rad Laboratories, Inc. (NYSE:BIO), compared with 44 in the previous quarter.

3. Amazon.com, Inc. (NASDAQ:AMZN)

Marshall and Wace’s Stake Value: $280,360,000
Percentage of Paul Marshall and Ian Wace’s 13F Portfolio: 1.26%
Number of Hedge Fund Holders: 271

Amazon.com, Inc. (NASDAQ:AMZN) is an online retailer that sells consumer items and subscriptions. The company was founded in 1994 and stands third on the list of Paul Marshall and Ian Wace’s stock picks.

Marshall Wace LLP holds 81,496 shares in Amazon.com, Inc. (NASDAQ:AMZN), worth over $280.36 million, representing 1.26% of their investment portfolio. There were 271 hedge funds in our database that held stakes in Amazon.com, Inc. (NASDAQ:AMZN) in the second quarter of 2021, compared to 243 funds in the previous quarter. 

L1 Capital, in its second-quarter 2021 investor letter, mentioned Amazon.com, Inc. (NASDAQ:AMZN). Here is what the fund said: 

Amazon flipped from being the largest detractor from portfolio performance in the March 2021 quarter, to one of the leading contributors in the June 2021 quarter. We took advantage of negative near-term sentiment in the March 2021 quarter to add to our Amazon investment. We continue to view Amazon as one of the best positioned businesses globally, with its share price still not reflecting fair value.”